InCarey
PrivateLast Round
Series C
Dec 22, 2021
Total Funding Raised
$76.8M
Company Overview
InCarey operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series C round in December 2021.
InCarey is a healthcare technology company that provides a cloud-based medical service platform for managing patients with chronic and special diseases, featuring professional disease management services, direct doctor-patient interactions, and an e-commerce platform for purchasing medications.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InCarey Comparables
Compare InCarey with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ClouDr Group | 83% | |
| GR Life Style Company Limited | 79% | |
| Fangzhou Inc. | 79% |
For institutional investors. Book with your work email.
InCarey Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 22, 2021 | ||||
| Series B Extension | Sep 14, 2020 | ||||
| Series B | Jun 1, 2019 | ||||
| Series A | Dec 1, 2015 | ||||
| Angel | Nov 4, 2011 |
For institutional investors. Book with your work email.
InCarey Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates | Series B Extension, Series C |
| Northern Light Venture Capital | Series A |
| Marathon Venture Partners | Series A, Series B |
| Huagai Capital | Series A |
| Long Hill Capital | Series B, Series C, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2021
$31M round led by New Enterprise Associates (NEA)
- Jun 1, 2019
Raised capital from Long Hill Capital and Marathon Venture Partners.
For institutional investors. Book with your work email.
InCarey Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InCarey's valuation, stock price, and market status.
Is InCarey a public or private company?
InCarey is a private company.
What is the current stock price of InCarey?
InCarey is a private company, so its shares have no public market price. Caplight tracks InCarey's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InCarey worth (valuation)?
Valuation information for InCarey is not publicly available.
Can I buy InCarey stock?
InCarey shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InCarey's last funding round?
InCarey's most recent funding round was Series C on December 22, 2021.
Who are the main investors in InCarey?
Key investors in InCarey include New Enterprise Associates, Northern Light Venture Capital, Long Hill Capital.
Will InCarey IPO soon?
No public IPO plans have been announced for InCarey.
How can I track InCarey secondary market activity?
Caplight tracks bids, offers, and trades in InCarey's shares on secondary markets.